A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
 


Dr. SergeBeaulieu, MD,PhD,FRCPC
Associate Professor (GFTU)


Bipolar disorders



Douglas Mental Health University Institute
6875 LaSalle Blvd, FBC Pavilion
Verdun
Quebec
H4H 1R3
514-761-6131 ext. 3301
514-888-4466

serge.beaulieu@mcgill.ca



Dr. Beaulieu spent four years at the National Institute of Mental Health with Dr. Robert M. Post at the Biological Psychiatry Branch. He is now at McGill University as an Associate Professor in the Department of Psychiatry and holds associate membership in the Department of Neurology and Neurosurgery. He is also the Medical Chief of the Mood, Anxiety and Impulsivity Disorders Program and Medical Chief of the Bipolar Disorder Program at the Douglas Mental Health University Institute. A psychiatrist and researcher-clinician, Dr. Beaulieu is interested primarily in bipolar disorders and major depression. He studies neurobiological responses to antidepressant and mood stabilizer treatment and potential new treatments for these disorders. Dr. Beaulieu received peer-reviewed research funding from NARSAD (National Alliance for Research on Schizophrenia and Affective Disorders) in the USA, The Stanley Foundation in the USA, the Canadian Fund for Innovation, FRSQ, and CIHR. He is also a member of the Board of Governors of CANMAT (Canadian Network on Mood and Anxiety Treatment) and one of the Investigators and founding members of the bipolar section of CANMAT. Dr. Beaulieu was a member of the Board of Councillors of ISBD (International Society of Bipolar Disorder) from 2006–2008. In 2004, he was the recipient of the Douglas Utting Prize, which is awarded annually to one person in Canada who has contributed significantly to promoting awareness of depression and/or its research and treatment. In addition, he received the prize of “Médecin-clinicien-enseignant” in 2009. This honour, awarded by the Quebec Medical Association, underlines the exceptional commitment of a doctor having a teaching responsibility in one of the faculties of medicine in Quebec.


Graduate: MSc, Neurobiology
Graduate: MD and PhD, Physiology, Laval University

Postgraduate Medical Training: Psychiatry, McGill University


The College of Physicians and Surgeons of Quebec
FMSQ (Federation of Medical Specialists of Quebec)

The Royal College of Physicians and Surgeons of Canada



Beaulieu S, Di Paolo T, Barden N. Implication of the serotoninergic system in the decreased ACTH response to stress after lesion of the amygdaloid central nucleus. Prog. Neuropsychopharmacol. Biol. Psychiatry. 1095;9(5-6):665-669.

Beaulieu S, Di Paolo T, Barden N. Control of ACTH secretion by the central nucleus of the amygdala: implication of the serotoninergic system and its relevance to the glucocorticoid delayed negative feedback mechanism. Neuroendocrinology. 1986;44(2):247-54. PubMed PMID: 3025760.

Beaulieu S, Di Paolo T, Côté J, Barden N. Participation of the central amygdaloid nucleus in the response of adrenocorticotropin secretion to immobilization stress: opposing roles of the noradrenergic and dopaminergic systems. Neuroendocrinology. 1987 Jan;45(1):37-46. PubMed PMID: 3027603.

Beaulieu S, Gagne B, Barden N. Glucocorticoid regulation of proopiomelanocortin messenger ribonucleic acid content of rat hypothalamus. Mol.Endocrinol. 1988;2(8):727-731.

Beaulieu S, Pelletier G, Vaudry H, Barden N. Influence of the central nucleus of the amygdala on the content of corticotropin-releasing factor in the median eminence. Neuroendocrinology. 1989;49(3):255-261.

Beaulieu S, Rousse I, Gratton A, Barden N, Rochford J. Behavioral and endocrine impact of impaired type II glucocorticoid receptor function in a transgenic mouse model. Ann. N.Y. Acad. Sci. 1994;746:388-391.

Beaulieu S. Stress and biology in mood disorders: Implications for treatment. Canadian Psychiatric Association Bulletin. 2000.

Yatham L, Kennedy SH, Schaffer A, Parikh SV, Beaulieu S, O’Donovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A, Young T, Young AH, Alda M, Eduard V, Calabrese J, Berk M, Ha K, Kapczinski F. Canadian Network for Mood and Anxiety Treatments (CANMAT) and Society for Bipolar Disorders (ISBD) Collaborative Update of CANMAT Guidelines for the Management of Patients with Bipolar Disorder: Update 2009. Bipolar Disorders. 2009;11:225-255.

Waddington Lamont E, Lalinec M, Beaulieu S, Ng Ying Kin NMK, Walker C- D, Boivin DB. Circadian variation of sleep and periodic limb movements in a bipolar man. Sleep Medicine. 2009;10:935-936.

Ng F, Berk M, Sachs GS, Wilting I, Ferrier IN, Cassidy F, Beaulieu S, Yatham L. The International Society of Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disorders. 2009;1:559-595.